Nirmatrelvir Plus Ritonavir for COVID-19: The First Step Is Getting the Name Right

被引：0
|
作者：
Wisniewski, Piotr [1 ,2 ]
Berjohn, Catherine M. [2 ]
Maves, Ryan C. [3 ,4 ]
机构：
[1] Naval Hlth Res Ctr, Operat Infect Dis Dept, San Diego, CA 92106 USA
[2] Naval Med Ctr San Diego, Div Infect Dis, San Diego, CA 92134 USA
[3] Wake Forest Univ Sch Med, Sect Infect Dis, Sch Med, Winston Salem, NC 27157 USA
[4] Wake Forest Univ, Sect Crit Care Med, Sch Med, Winston Salem, NC 27157 USA
来源：
MILITARY MEDICINE | 2023年 / 188卷 / 1-2期
关键词：
D O I：
10.1093/milmed/usac359
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：34 / 35
页数：2
相关论文
共 50 条
  • [31] The Efficacy and Safety of Nirmatrelvir/Ritonavir Against COVID-19 in Elderly Patients
    Xiang, Zheng
    Wang, Yueyuan
    Qu, Yuchen
    Lv, Bo
    Han, Junping
    Xu, Delai
    Fan, Kai
    Su, Cunjin
    Shen, Zhu
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17
  • [32] Pediatric Nirmatrelvir/Ritonavir Prescribing Patterns During the COVID-19 Pandemic
    Bose-Brill, Seuli
    Hirabayashi, Kathryn
    Schwimmer, Emmanuel
    Pajor, Nathan M.
    Rao, Suchitra
    Mejias, Asuncion
    Jhaveri, Ravi
    Forrest, Christopher B.
    Bailey, L. Charles
    Christakis, Dimitri A.
    Thacker, Deepika
    Hanley, Patrick C.
    Patel, Payal B.
    Cogen, Jonathan D.
    Block, Jason P.
    Prahalad, Priya
    Lorman, Vitaly
    Lee, Grace M.
    [J]. HOSPITAL PEDIATRICS, 2024, 14 (08) : e341 - e348
  • [33] Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19
    Sutanto, Samuel Theodorus
    Sinto, Robert
    Pasaribu, Adeline
    Shakinah, Sharifah
    [J]. ACTA MEDICA INDONESIANA, 2022, 54 (04) : 638 - 644
  • [34] Comparison of Azvudine and Nirmatrelvir/ Ritonavir and Combined Use in Patients with COVID-19
    Hu, Cheng-Yi
    Cui, Wen-Shuai
    Lei, Yi
    Tang, Yu-Wen
    Zhang, Yan-Yan
    Su, Qi-Min
    Peng, Fang
    Zeng, Yun-Fei
    Song, Jia-Lin
    Luo, Cheng-Na
    Zhou, Yan
    Li, Xin-Yan
    Zhao, Zhu-Xiang
    [J]. INFECTION AND DRUG RESISTANCE, 2023, 16 : 7797 - 7808
  • [35] Efficacy and safety of Nirmatrelvir/Ritonavir for treating the Omicron variant of COVID-19
    Qiu, Chaochao
    Wu, Zhengxing
    Liu, Xiaojing
    Zhang, Qiang
    Wu, Lianpeng
    Ye, Xinchun
    Zhou, Jiajun
    Shi, Jichan
    Jiang, Xiangao
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [36] Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era
    Faraz, Fatima
    Rehman, Mohammad Ebad Ur
    Shahid, Abia
    Ghafoor, Muhammad Saqib
    Cheema, Huzaifa Ahmad
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (11) : 1017 - 1019
  • [37] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19
    Focosi, Daniele
    Nicastri, Emanuele
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (10)
  • [38] Safety of Nirmatrelvir/Ritonavir in Dialysis Patients with COVID-19 The End of the Beginning?
    Yilmam, Osman A. A.
    Leaf, David E. E.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (04): : 427 - 429
  • [39] Nirmatrelvir+ritonavir-related AEs in patients with COVID-19 infections
    [J]. Reactions Weekly, 2023, 1957 (1) : 11 - 11
  • [40] No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir
    Palomino-Cabrera, Rosalia
    Tejerina, Francisco
    Molero-Salinas, Andrea
    Veintimilla, Cristina
    Catalan, Pilar
    Ferris, Maria
    Osorio, Santiago
    Alonso, Roberto
    Munoz, Patricia
    de Viedma, Dario de Garcia
    Perez-Lago, Laura
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (01)
12345